The study demonstrated that high sHLA-G levels before neoadjuvant chemotherapy are closely correlated with disease progression, and the detection of stem cell-like CTCs (SL-CTCs) rendered them as major contributors to tumor immune escape and survival in the peripheral blood by expressing HLA-G or secreting sHLA-G [19]. Here, HLA-G is linked to neoplasm.